FAVIJAJ 200 Tablet 10's

Viral infections Rx required
OUT OF STOCK

Best Price*  ₹ 440.00
MRP ₹550.00
(Inclusive of all taxes) *10 Tablet(s) in a Strip * Mkt: BAJAJ HEALTHCARE LTD * Country of Origin: India * Delivery charges if applicable will be applied at checkout



INTRODUCTION

FAVIJAJ 200 contains Favipiravir which belongs to a group of medicines called antiviral agents. It is indicated for the treatment of patients with mild to moderate COVID-19 disease. This medicine does not treat bacterial infections. Coronavirus disease (Covid-19) is a highly infectious disease which caused by a strain of a virus called coronavirus. The common symptoms are fever, cough, loss of taste or smell, breathing difficulty, nasal congestion and diarrhea.

Always take this FAVIJAJ 200 exactly as directed by your doctor. Before taking this medicine, tell your physician if you have liver, kidney or heart problems. It is not recommended for pregnant women and breastfeeding mothers. It is not suitable for use in children. The common side effects are increase in blood uric acid levels, reduction in white blood cells count, diarrhoea and increase in liver enzymes.

USES OF FAVIJAJ 200

  • Treats mild to moderate coronavirus 2 (SARS-CoV-2) infection in adults

HOW FAVIJAJ 200 WORKS

RNA polymerase is the enzyme which helps SARS-CoV-2 virus to make new RNA, so it is essential for the virus to make more copies of itself in the body. Favipiravir selectively targets this enzyme, to inhibit the replication of the COVID-19 causing virus in the body.

DIRECTIONS FOR USE

Always take this FAVIJAJ 200 exactly as your doctor has told you. Swallow as whole and do not crush or chew. Do not exceed the recommended dose.

SIDE EFFECTS OF FAVIJAJ 200

COMMON

  • increase in blood uric acid levels
  • diarrhoea
  • reduction in white blood cells count
  • increase in liver enzymes

HOW TO MANAGE SIDE EFFECTS

Diarrhoea:

Drink plenty of fluids to avoid dehydration. ORS can be used to prevent dehydration.

WARNING & PRECAUTIONS

PREGNANCY

FAVIJAJ 200 is not recommended for use in pregnant women unless necessary. Consult your doctor for advice.

BREASTFEEDING

FAVIJAJ 200 is not recommended for use in breastfeeding women unless necessary. Consult your doctor for advice.

DRIVING AND USING MACHINES

Do not drive or operate any machines if you have abnormal behaviour or impaired concentration while taking this FAVIJAJ 200.

KIDNEY

FAVIJAJ 200 is not recommended in patients with active kidney diseases. Consult your doctor for advice.

LIVER

FAVIJAJ 200 is not recommended in patients with active liver diseases. Consult your doctor for advice.

ALLERGY

Do not take if you are allergic (hypersensitive) to Favipiravir.

OTHERS

Tell your doctor before taking this medicine if you have or had:

  • history of gout or hyperuricaemia
  • any other medical condition

INTERACTIONS

Tell your doctor if you are taking,

  • pyrazinamide (treats tuberculosis)
  • repaglinide (treats high blood sugar)
  • theophylline (treats asthma or breathing problems)
  • famciclovir, oseltamivir (treats antiviral infection)
  • sulindac (relieves pain)

SYNOPSIS

Drug :   Favipiravir
Pharmacological Category :   Antiviral agents
Therapeutic Indication :   Mild to moderate COVID-19 disease
Dosage Forms :   Tablet

MORE INFORMATION

Store at room temperature and keep out of reach of children.

FAQs ABOUT FAVIJAJ 200

Can FAVIJAJ 200 be used during pregnant or breastfeeding?

No, this medicine should not be used for treating Covid-19 infection in pregnant or breastfeeding women.  If you are planning a baby, pregnant or breastfeeding, consult your doctor if you are tested positive for Covid-19 or even if you are suspected of Covid-19 infection.

How does FAVIJAJ 200 work?

It inhibits replication (a process by which this virus multiplies) of the Covid-19 virus and stops the further spread of the infection.

For how long and in what dose should FAVIJAJ 200 be taken?

It must be taken in the dose and duration advised by the doctor.

REFERENCES

1. Umang Agrawal, Reyma Raju and Zarir F. Udwadia. Favipiravir: A new and emerging antiviral option in COVID-19. Oct, 2020. [Accessed on May 11, 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467067/

2. Shashank Joshi., Jalil Parkar, Abdul Ansari, Mangesh Tiwaskar, Saiprasad Patil and Hanmant Barkate. Role of Favipiravir in the treatment of COVID-19. October 29, 2020. [Accessed on May 11, 2021] https://www.ijidonline.com/article/S1201-9712(20)32273-6/fulltext

3. Cipla Ltd. July 23, 2020. [Revised on Nov 27, 2020] [Accessed on May 11, 2021] https://www.ciplamed.com/printpdf/47598

4. Glenmark Pharmaceuticals Limited. June, 2020. [Accessed on May 11, 2021] https://www.glenmarkpharma.com/sites/default/files/Glenmark-FabiFlu-Press-Brief.pdf

USEFUL DIAGNOSTIC TESTS

  • RT PCR test

PRODUCT DETAILS

    Hsn Code
    30049099
ALTERNATE BRANDS View All
FAVILOW 200 Tablet 10's
Prescription Viral infections Rx required
Rs.330.00
TORFAVI 200 Tablet 10's
Prescription Viral infections Rx required
Rs.450.00
CODIFAB 200 Tablet 34's
Prescription Viral infections Rx required
Rs.2,346.00
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright© 2021. All Rights Reserved.